AR003932A1 - Oxidiazoles procineticos, su uso como medicamento, una composicion farmaceutica que los contiene, un procedimiento para preparar dicha composicion - Google Patents
Oxidiazoles procineticos, su uso como medicamento, una composicion farmaceutica que los contiene, un procedimiento para preparar dicha composicionInfo
- Publication number
- AR003932A1 AR003932A1 ARP960101592A AR10159296A AR003932A1 AR 003932 A1 AR003932 A1 AR 003932A1 AR P960101592 A ARP960101592 A AR P960101592A AR 10159296 A AR10159296 A AR 10159296A AR 003932 A1 AR003932 A1 AR 003932A1
- Authority
- AR
- Argentina
- Prior art keywords
- alkyl
- represents hydrogen
- alc
- formula
- radical
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 229940126601 medicinal product Drugs 0.000 title 1
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 5
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 5
- 229910052739 hydrogen Inorganic materials 0.000 abstract 4
- 239000001257 hydrogen Substances 0.000 abstract 4
- 125000004916 (C1-C6) alkylcarbonyl group Chemical group 0.000 abstract 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical group C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 abstract 2
- 125000003545 alkoxy group Chemical group 0.000 abstract 2
- 125000003118 aryl group Chemical group 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 2
- 229940079593 drug Drugs 0.000 abstract 2
- 125000001475 halogen functional group Chemical group 0.000 abstract 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 2
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 1
- 125000004738 (C1-C6) alkyl sulfinyl group Chemical group 0.000 abstract 1
- 125000004739 (C1-C6) alkylsulfonyl group Chemical group 0.000 abstract 1
- WNXJIVFYUVYPPR-UHFFFAOYSA-N 1,3-dioxolane Chemical group C1COCO1 WNXJIVFYUVYPPR-UHFFFAOYSA-N 0.000 abstract 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical group C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 abstract 1
- 125000006577 C1-C6 hydroxyalkyl group Chemical group 0.000 abstract 1
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 abstract 1
- 125000003601 C2-C6 alkynyl group Chemical group 0.000 abstract 1
- 125000000815 N-oxide group Chemical group 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 125000005129 aryl carbonyl group Chemical group 0.000 abstract 1
- 210000001072 colon Anatomy 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 230000003247 decreasing effect Effects 0.000 abstract 1
- 150000002012 dioxanes Chemical class 0.000 abstract 1
- 150000004862 dioxolanes Chemical group 0.000 abstract 1
- 150000004866 oxadiazoles Chemical class 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Chemical group C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nutrition Science (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Abstract
La presente invención se relaciona con nuevos oxadiazoles procinéticos de la fórmula (I), las formas de N-óxido, las sales de adición de ácidofarmacéuticamente aceptables y las formas estereoquímicamente isoméricas de los mismos, donde R1 eshidróg eno o halo; R2 representa alquilo C1-6, alqueniloC2-6 o alquinilo C2-6; R3 representa hidrógeno; ó R2 y R3 conjuntamente pueden formar un radical alcandiilo C2-3 donde uno o dos átomos de hidrógeno puedenestas reemplazados por alquilo C1-4;R4 repre senta hidrógeno o alquiloxi C1-6; X es un radical bivalente de la fórmula (a.1) o (a.2); L es un radical de lafórmula -Alc-R5 o Alc-O-R6, Alc representa alcandiilo C1-12; R5 representa hidrógeno, ciano, alquilcabonilo C1-6,alquilsulfinilo C1-6 , alquilsulfoniloC1-6, arilo, arilcarbonilo, tetrahidrofurano, dioxolano, dioxolano substituido con alquilo C1-6, dioxano, dioxano substituido con alquilo C1-6; R6 representahidrógeno,arilo, alquilo C1-6, hidroxialquilo C1-6,alquilcarbonilo C1-6; a rilo se define como fenilo o fenilo substituido con hasta tres substituyentesseleccionados entre halo, alquilo C1-6 o alquiloxi C1-6. Además se revelan composiciones farmacéuticas que los comprenden, un proceso paralapreparación de dichos compu estos y composiciones y con el uso de los mismos como medicamentos, en particular en las condiciones que involucran unadisminuida movilidad del colon.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP95200501 | 1995-03-01 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR003932A1 true AR003932A1 (es) | 1998-09-30 |
Family
ID=8220055
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP960101592A AR003932A1 (es) | 1995-03-01 | 1996-02-29 | Oxidiazoles procineticos, su uso como medicamento, una composicion farmaceutica que los contiene, un procedimiento para preparar dicha composicion |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US5854261A (es) |
| EP (1) | EP0812321B1 (es) |
| JP (1) | JP3980056B2 (es) |
| KR (1) | KR100443554B1 (es) |
| CN (1) | CN1092656C (es) |
| AR (1) | AR003932A1 (es) |
| AT (1) | ATE384716T1 (es) |
| AU (1) | AU702932B2 (es) |
| BR (1) | BR9607316A (es) |
| CA (1) | CA2212893C (es) |
| CZ (1) | CZ286992B6 (es) |
| DE (1) | DE69637412T2 (es) |
| EA (1) | EA001084B1 (es) |
| ES (1) | ES2301166T3 (es) |
| FI (1) | FI973562A7 (es) |
| HU (1) | HUP9702395A3 (es) |
| IL (1) | IL117315A (es) |
| MY (1) | MY113584A (es) |
| NO (1) | NO309425B1 (es) |
| NZ (1) | NZ301699A (es) |
| PL (1) | PL183712B1 (es) |
| TR (1) | TR199700876T1 (es) |
| TW (1) | TW360653B (es) |
| WO (1) | WO1996026937A1 (es) |
| ZA (1) | ZA961652B (es) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9603755D0 (en) * | 1996-02-22 | 1996-04-24 | Pfizer Ltd | Therapeutic agents |
| US6107313A (en) * | 1998-10-02 | 2000-08-22 | Combichem, Inc. | Dopamine receptor antagonists |
| US7332508B2 (en) * | 2002-12-18 | 2008-02-19 | Novo Nordisk A/S | Substituted homopiperidine, piperidine or pyrrolidine derivatives |
| GB0910667D0 (en) * | 2009-06-19 | 2009-08-05 | Glaxo Wellcome Mfg Pte Ltd | Novel compounds |
| KR101551481B1 (ko) * | 2011-09-19 | 2015-09-08 | 수벤 라이프 사이언시스 리미티드 | ５－ηｔ４ 수용체 리간드인 헤테로아릴 화합물 |
| JP2019533022A (ja) * | 2016-10-24 | 2019-11-14 | ユマニティ セラピューティクス，インコーポレーテッド | 化合物及びその使用 |
| ES3025460T3 (en) | 2017-01-06 | 2025-06-09 | Janssen Pharmaceutica Nv | Scd inhibitor for the treatment of neurological disorders |
| CA3083000A1 (en) | 2017-10-24 | 2019-05-02 | Yumanity Therapeutics, Inc. | Compounds and uses thereof |
| EP3768269B1 (en) | 2018-03-23 | 2025-08-20 | Janssen Pharmaceutica NV | Compounds and uses thereof |
| WO2020154571A1 (en) | 2019-01-24 | 2020-07-30 | Yumanity Therapeutics, Inc. | Compounds and uses thereof |
| EA202192047A1 (ru) | 2019-11-13 | 2021-12-08 | Юманити Терапьютикс, Инк. | Соединения и их применение |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1183847A (en) * | 1981-10-01 | 1985-03-12 | Georges Van Daele | N-(3-hydroxy-4-piperidinyl)benzamide derivatives |
| US5374637A (en) * | 1989-03-22 | 1994-12-20 | Janssen Pharmaceutica N.V. | N-(3-hydroxy-4-piperidinyl)(dihydrobenzofuran, dihydro-2H-benzopyran or dihydrobenzodioxin)carboxamide derivatives |
| GB9005014D0 (en) * | 1990-03-06 | 1990-05-02 | Janssen Pharmaceutica Nv | N.(4.piperidinyl)(dihydrobenzofuran or dihydro.2h.benzopyran)carboxamide derivatives |
| EP0596933A1 (en) * | 1991-08-03 | 1994-05-18 | Smithkline Beecham Plc | 5-ht4 receptor antagonists |
| GB9202797D0 (en) | 1992-02-11 | 1992-03-25 | Milsom Jonathan | Glazed units |
| CA2146930A1 (en) * | 1992-10-13 | 1994-04-28 | Francis David King | Heterocyclic -esters or -amides used as 5-ht4 receptor antagonists |
| MX9306311A (es) * | 1992-10-13 | 1994-04-29 | Smithkline Beecham Plc | Compuestos antagonistas del receptor de 5-ht4, procedimiento para su preparacion y composiciones farmaceuticas que los contienen |
| WO1994010174A1 (en) * | 1992-11-05 | 1994-05-11 | Smithkline Beecham Plc | Piperidine derivatives as 5-ht4 receptor antagonists |
| JPH06157518A (ja) * | 1992-11-27 | 1994-06-03 | Yamanouchi Pharmaceut Co Ltd | 新規なオキサジアゾール誘導体又はその塩 |
| WO1995032965A1 (en) * | 1994-06-01 | 1995-12-07 | Yamanouchi Pharmaceutical Co. Ltd. | Oxadiazole derivative and medicinal composition thereof |
-
1996
- 1996-02-15 TW TW085101860A patent/TW360653B/zh not_active IP Right Cessation
- 1996-02-21 US US08/894,340 patent/US5854261A/en not_active Expired - Lifetime
- 1996-02-21 ES ES96903000T patent/ES2301166T3/es not_active Expired - Lifetime
- 1996-02-21 CZ CZ19972723A patent/CZ286992B6/cs not_active IP Right Cessation
- 1996-02-21 DE DE69637412T patent/DE69637412T2/de not_active Expired - Lifetime
- 1996-02-21 AT AT96903000T patent/ATE384716T1/de not_active IP Right Cessation
- 1996-02-21 PL PL96322019A patent/PL183712B1/pl not_active IP Right Cessation
- 1996-02-21 EA EA199700205A patent/EA001084B1/ru not_active IP Right Cessation
- 1996-02-21 AU AU47188/96A patent/AU702932B2/en not_active Ceased
- 1996-02-21 KR KR1019970705701A patent/KR100443554B1/ko not_active Expired - Fee Related
- 1996-02-21 BR BR9607316A patent/BR9607316A/pt not_active Application Discontinuation
- 1996-02-21 HU HU9702395A patent/HUP9702395A3/hu unknown
- 1996-02-21 NZ NZ301699A patent/NZ301699A/en not_active IP Right Cessation
- 1996-02-21 WO PCT/EP1996/000784 patent/WO1996026937A1/en not_active Ceased
- 1996-02-21 CA CA002212893A patent/CA2212893C/en not_active Expired - Lifetime
- 1996-02-21 CN CN96192300A patent/CN1092656C/zh not_active Expired - Fee Related
- 1996-02-21 EP EP96903000A patent/EP0812321B1/en not_active Expired - Lifetime
- 1996-02-21 JP JP52601096A patent/JP3980056B2/ja not_active Expired - Lifetime
- 1996-02-21 TR TR97/00876T patent/TR199700876T1/xx unknown
- 1996-02-29 MY MYPI96000748A patent/MY113584A/en unknown
- 1996-02-29 ZA ZA9601652A patent/ZA961652B/xx unknown
- 1996-02-29 IL IL11731596A patent/IL117315A/xx not_active IP Right Cessation
- 1996-02-29 AR ARP960101592A patent/AR003932A1/es unknown
-
1997
- 1997-08-19 NO NO973808A patent/NO309425B1/no not_active IP Right Cessation
- 1997-08-29 FI FI973562A patent/FI973562A7/fi not_active Application Discontinuation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0302474A2 (hu) | Terápiásan hatásos tropánszármazékok, eljárás az előállításukra, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk | |
| MX9700890A (es) | 1, 4-benzotiazepina-1, 1-dioxidos hipolipidemicos. | |
| AR032136A1 (es) | Compuestos espiroheterociclicos utiles como inhibidores reversibles de cisteina-proteasas | |
| AR037517A1 (es) | Derivados de naftiridinas, un proceso para su preparacion, composicion farmaceutica y el uso de los mismos para la preparacion de un medicamento para el tratamiento de una enfermedad inflamatoria | |
| AR007827A1 (es) | 3-ureido-piridofuranos y -piridotiofenos, procedimiento para su preparacion, composicion que los comprende y uso de dichos compuestos para lapreparacion de medicamentos. | |
| AR024060A1 (es) | Nuevos compuestos farmaceuticamente activos | |
| CO5180642A1 (es) | Compuestos sustituidos de piperidina, procesos para su prepa racion, composiciones farmaceuticas que los contienen y su utilizacion | |
| BRPI0108395B8 (pt) | derivados de pirrolopirimidinona, processos de preparação e uso | |
| ES2194265T3 (es) | Derivados de piperidino 4-carboxamida y su utilizacion como antagonistas de la neuroquinina. | |
| CR7743A (es) | Nuevos compuestos de oxazol y tiazol como inhibidorea del factor de crecimiento transformador (tgf) | |
| ECSP941104A (es) | Derivados de 2,6 diaminopurina, procedimiento para su preparacion y composiciones farmaceuticas que los contienen | |
| ES2052603T3 (es) | Derivados de bencimidazol, procedimiento para su produccion y composicion farmaceutica que los contienen. | |
| AR037329A1 (es) | Compuestos pirazolo pirimidinona, procedimientos para la preparacion de los mismos, composiciones farmaceuticas de los mismos y usos de los mismos en la preparacion de medicamentos | |
| AR003932A1 (es) | Oxidiazoles procineticos, su uso como medicamento, una composicion farmaceutica que los contiene, un procedimiento para preparar dicha composicion | |
| PA8551001A1 (es) | Nuevos compuestos | |
| ES2123039T3 (es) | Nuevas 3-(hidroxi-bencilidenil)-indolin-2-onas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen. | |
| AR002244A1 (es) | Nuevos derivados de [3-(4-fenilpiperacin-1-il)propilamino]-piridina y benceno como antagonistas de ó 1-andrenoceptores, una composicion farmaceuticaque los contiene, un procedimiento para su preparacion y empleo de los mismos. | |
| AR007079A1 (es) | Derivados de alquilaminobenzotiazol y benzoxazol , un proceso para su preparación, una composición farmacéutica que los contiene, y un proceso para preparar dicha composición | |
| UY27410A1 (es) | Formas novedosas crudas cristalinas | |
| AR016480A1 (es) | Azoles hidrosolubles como antifungicos de amplio espectro, un proceso para su preparacion, un intermediario y una composicion farmaceutica que los comprende y el uso d elos mismos en la elaboracion de un medicamento | |
| ES2176321T3 (es) | Derivados tetrasustituidos del imidazol, su procedimiento de preparacion, su aplicacion como medicamentos y las composiciones farmaceuticas que los contienen. | |
| UA50711C2 (uk) | Антрациклінові похідні, їх застосування при лікуванні амілоїдозу та фармацевтична композиція | |
| MX9300628A (es) | Nuevos derivados de taxano, procedimiento para su preparacion y composicion farmaceutica que los contiene. | |
| ZA806399B (en) | New 2-hydroxyalkyl-3,4,5-trihydroxypiperidine compounds, their production and their medicinal use | |
| AR032622A1 (es) | Compuestos de 4-amino-azepan-3-ona, composiciones farmaceuticas que los comprenden, intermediarios utiles en la sintesis de tales compuestos, procedimiento para la sintesis de dichos compuestos, y uso de tales compuestos en la fabricacion de medicamentos |